FDA Warned Pregnant Women against the use of Popular Weight-loss Drugs Ozempic and Wegovy

The Food and Drug Administration (FDA) recently warned women who are planning to get pregnant, at least two months prior, to avoid taking semaglutide drugs, particularly the brands Ozempic and Wegovy, due to the findings from animal studies.  Likely to be worth $100 billion a year, the two brands are marketed for weight loss and […]

The post FDA Warned Pregnant Women against the use of Popular Weight-loss Drugs Ozempic and Wegovy appeared first on News Magazine.